Patent Yard Sign in
European application, no grantEurope

Recombinant pox virus for immunization against muc1 tumor-associated antigen

EP 1012276 A2 · Applicant: DANA-FARBER CANCER INSTITUTE

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed February 24, 1998 and never granted as a European patent. Had it been granted, its 20-year term would have ended February 24, 2018.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by August 24, 2023.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledFebruary 24, 1998
PublishedJune 28, 2000
GrantedNever granted
Term endedFebruary 24, 2018
Application numberEP 98906706
Classification (CPC)C07K14/705 +2 more

Timeline

Timeline From EPO dates

1999200120032005200720092011201320152017Application filedFeb 24, 1998PublishedJune 28, 2000Term endedFeb 24, 2018

Sources & verification